Chercheur

    Anick Bérard , Ph.D.

    anick.berard@umontreal.ca
    Anick Bérard
    Axe de recherche
    Pathologies fœtomaternelles et néonatales
    Thème de recherche
    Grossesses à risque
    Adresse
    CHUSJ - Centre de Recherche

    Téléphone
    514 345-4931 #4363

    Fax
    514 345-4801

    Sur le Web

    Titres

    • Chercheur, Centre de recherche, CHU Sainte-Justine
    • Professeur titulaire, Faculté de pharmacie, Université de Montréa
    • Professeur associé, Université Claude Bernard, Lyon, France
    • Professeur associé, Université de Zhengzhou, Chine
    • Professeur associé, Albert Einstein College of Medicine
    • Directrice, Réseau FRQS de recherche sur les médicaments

    Formation

    • Postdoctorat en pharmacoépidémiologie, Harvard Medical School, Boston, É.-U., 2000
    • PhD en épidémiologie et biostatistiques, Université McGill, 1999
    • MSc en sciences cliniques, Université de Sherbrooke, 1993
    • BSc en statistiques, Université Laval, 1989

    Intérêts de recherche

    • Médicaments, grossesse et allaitement;
    • Antidépresseurs, dépression, anxiété et stress en cours de grossesse et postpartum;
    • Méthodes de procréation assistées;
    • Antibiotiques;
    • Acide folique.

    Sommaire de carrière

    Consultez également le site web Médicaments et grossesses

    Principaux projets en cours

    • Études TWINPREG et AtRISK : Quantifier les risques de grossesse multiple et de malformations congénitales majeures associés à l’utilisation des méthodes de procréation assistées. Subventionnées par le Ministère de la Santé et des Services sociaux du Québec et les Instituts de recherche en santé du Canada (IRSC).
    • Antidépresseurs et grossesse : La durée d’utilisation des antidépresseurs durant la grossesse et le développement cognitif de l’enfant jusqu’à l’âge de 5 ans. Étude internationale subventionnée par les IRSC, le Fonds de la recherche en santé du Québec (FRSQ) et le Conseil du médicament du Québec.
    • Utilisation des antibiotiques durant la grossesse et risque d’évènements indésirables chez l’enfant. Subventionnée par les IRSC.
    • Utilisation des médicaments durant la grossesse et risques pour la mère et l’enfant. Subventionnée par le Réseau québécois de recherche sur l’utilisation du médicament.
    • Utilisation de fortes doses d’acide folique durant la grossesse et risques pour le foetus.
    • Étude COEFFICIENTS : Estimation de coefficients d’ajustement pour les variables manquantes dans les banques de données administratives du Québec. Subventionnée par le FRSQ.

    Prix et distinctions

    • Directrice, Réseau FRQS de recherche sur les médicaments
    • Most dinstinguished scientist award, Teratology Society
    • Bourse salariale de nouveau chercheur, Instituts de recherche en santé du Canada (IRSC)
    • Titulaire, Chaire de recherche du FRQS Médicaments et grossesse
    • Titulaire, Chaire de recherche de la Famille Louis Boivin - médicaments, grossesse et allaitement, Université de Montréal/Centre de recherche CHU Sainte-Justine
    • Chercheur-boursier Junior 2, Fonds de recherche du Québec - Santé (FRQS)
    • Présidente élue, Association canadienne pour la thérapeutique de population

Publications

Dihydroergotamine (DHE) use during gestation and the risk of adverse pregnancy outcomes - Bérard A, Kori S. Dihydroergotamine (DHE) use during gestation and the risk of adverse pregnancy outcomes. Headache 2012; 52(7): 1085-1093.

Study of the costs and morbidities of late-preterm birth - Bérard A, Le Tiec M, De Vera MA. Study of the costs and morbidities of late-preterm birth. Arch Dis Child Fetal Neonatal Ed 2012; 97(5): F329-F334.

Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in quebec and france: a short communication - Bérard A, Sheehy O, Damase-Michel C, Crespin S. Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in quebec and france: a short communication. Curr Drug Saf 2012; 7(3): 207-210.

Do drug warnings and market withdrawals have an impact on the number of calls to teratogen information services? - Sheehy O, Gendron M-P, Martin B, Bérard A. Do drug warnings and market withdrawals have an impact on the number of calls to teratogen information services?. Pharmacopsychiatry 2012; 45(4): 146-151.

Concordance between periconceptional folic acid supplementation and Canadian Clinical Guidelines - Richard-Tremblay AA, Sheehy O, Audibert F, Ferreira E, Bérard A. Concordance between periconceptional folic acid supplementation and Canadian Clinical Guidelines. J Popul Ther Clin Pharmacol 2012; 19(2): e150-159.

Exposure to specific herbal products during pregnancy and the risk of low birth weight - Moussally K, Bérard A. Exposure to specific herbal products during pregnancy and the risk of low birth weight. Altern Ther Health Med 2012; 18(2): 36-43.

Reliability and validity of the 4-item perceived stress scale among pregnant women: results from the OTIS antidepressants study - Karam F, Bérard A, Sheehy O, Huneau MC, Briggs G, Chambers C, Einarson A, Johnson D, Kao K, Koren G, Martin B, Polifka J, Riordan S, Roth M, Lavigne SV, Wolfe L, OTIS Research Committee. Reliability and validity of the 4-item perceived stress scale among pregnant women: results from the OTIS antidepressants study. Res Nurse Health 2012; 35(4): 363-375.

Use of anti-infective drugs during pregnancy and the risk of preterm birth - Santos F, Sheehy O, Perreault S, Ferreira E, Bérard A. Use of anti-infective drugs during pregnancy and the risk of preterm birth. Int J Antimicrob Agents 2012; 39(2): 177-178.

Antidepressant use during pregnancy and the risk of pregnancy induced hypertension - De Vera MA, Bérard A. Antidepressant use during pregnancy and the risk of pregnancy induced hypertension. Brit J Clin Pharmacol 2012; 74(2): 362-369.

Relationship between changes in inhaled corticosteroid use and markers of uncontrolled asthma during pregnancy - Blais L, Firoozi F, Kettani FZ, Ducharme F, Lemiere C, Beauchesne MF, Bérard A. Relationship between changes in inhaled corticosteroid use and markers of uncontrolled asthma during pregnancy. Pharmacotherapy 2012; 32(3): 202-209.

Quality assessment of clinical practice guidelines for the prescription of antidepressant drugs during pregnancy - Santos F, Sola I, Rigau D, Arevalo-Rodriguez I, Seron P, Alonso-Coello P, Bérard A, Bonfill X. Quality assessment of clinical practice guidelines for the prescription of antidepressant drugs during pregnancy. Curr Clin Pharmacol 2012; 7(1): 7-14.

Isotretinoin and the risk of cardiovascular, cerebrovascular and thromboembolic disorders - Bérard A, Azoulay L, Nakhai-Pour HR, Moussally K. Isotretinoin and the risk of cardiovascular, cerebrovascular and thromboembolic disorders. Dermatology 2011; 223(1): 45-51.

Urinary tract infections during pregnancy - Bérard A, Santos F, Ferreira E, Perreault S. Urinary tract infections during pregnancy. Dans: Trenke P (ed.). Urinary Tract Infections. InTech, 2011; 113-132.

Exposure to anti-infective drugs during pregnancy and the risk of small-for-gestational-age newborns: a case-control study - Santos F, Sheehy O, Perreault S, Ferreira E, Bérard A. Exposure to anti-infective drugs during pregnancy and the risk of small-for-gestational-age newborns: a case-control study. BJOG 2011; 118(11): 1374-1382.

Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion - Nakhai-Pour HR, Broy P, Sheehy O, Bérard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ 2011; 183(15): 1713-1720.

Antiepileptic drug use during pregnancy: perinatal outcomes - Kulaga S, Sheehy O, Zargarzadeh A, Moussally K, Bérard A. Antiepileptic drug use during pregnancy: perinatal outcomes. Seizure 2011; 20(9): 667-672.

Les soins fondés sur la preuve: atteinte des compétences des étudiants de premier cycle en pharmacie - Beauchesne MF, Gardner D, Ferreira E, Bérard A, Zed P, Blais L. Les soins fondés sur la preuve: atteinte des compétences des étudiants de premier cycle en pharmacie. Pharmactuel 2011; 44: 162-163.

Paroxetine exposure during pregnancy and the risk of cardiac malformations: What is the evidence? - Bérard A. Paroxetine exposure during pregnancy and the risk of cardiac malformations: What is the evidence?. Birth Defects Res Part A Clin Mol Teratol 2010; 88(3): 171-174.

Use of antidepressants during pregnancy and the risk of spontaneous abortion - Nakhai-Pour HR, Broy P, Bérard A. Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ 2010; 182(10): 1031-1037.

Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns - Nakhai-Pour HR, Rey E, Bérard A. Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Res Part B Dev Reprod Toxicol 2010; 89(2): 147-154.

Gestational exposure to antidepressants and the risk of spontaneous abortion: A review - Broy P, Bérard A. Gestational exposure to antidepressants and the risk of spontaneous abortion: A review. Curr Drug Deliv 2010; 7(1): 76-92.

Congenital malformations: agreement between diagnostic codes in an administrative database and mothers' reports - Kulaga S, Bérard A. Congenital malformations: agreement between diagnostic codes in an administrative database and mothers' reports. J Obstet Gynaecol Can 2010; 32(6): 549-554.

Exposure to herbal products during pregnancy and the risk of preterm birth - Moussally K, Bérard A. Exposure to herbal products during pregnancy and the risk of preterm birth. Eur J Obstet Gynecol Reprod Biol 2010; 150(1): 107-108.

Antidepressant use during pregnancy: A critical systematic review of the literature - Simoncelli L, Martin B, Bérard A. Antidepressant use during pregnancy: A critical systematic review of the literature. Curr Drug Saf 2010; 5(2): 153-170.

Association between antidepressant use during pregnancy and infants born small for gestational age - Ramos É, St-André M, Bérard A. Association between antidepressant use during pregnancy and infants born small for gestational age. Can J Psychiatry 2010; 55(10): 643-652.

Birth outcomes in women who have taken leflunomide during pregnancy - Chambers C, Johnson D, Robinson LK, Braddock S, Xu R, Lopez-Jimenez J, Mirrasoul N, Salas E, Luo YJ, Jin S, Jones K, Bérard A, Organization of Teratology Information Specialists Collaborative Research Group. Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum/Ar C Res 2010; 62(5): 1494-1503.

CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction - Gaedigk A, Fuhr U, Johnson C, Bérard A, Bradford LD, Leeder JS. CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction. Pharmacogenomics 2010; 11(1): 43-53.

Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs - Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, Perreault S. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care 2010; 48(5): 418-425.

Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting - Dragomir A, Côté R, White M, Lalonde L, Blais L, Bérard A, Perreault S. Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. Value in Health 2010; 13(1): 87-94.

Effect of maternal moderate to severe asthma on perinatal outcomes - Firoozi F, Lemiere C, Ducharme F, Beauchesne MF, Perreault S, Bérard A, Ferreira E, Forget A, Blais L. Effect of maternal moderate to severe asthma on perinatal outcomes. Respir Med 2010; 104(9): 1278-1287.

Prevalence and predictors of anti-infective use during pregnancy - Santos F, Oraichi D, Bérard A. Prevalence and predictors of anti-infective use during pregnancy. Pharmacoepidemiol Drug Safety 2010; 19(4): 418-427.

Adherence level of antihypertensive agents in coronary artery disease - Perreault S, Dragomir A, Roy L, White M, Blais L, Lalonde L, Bérard A. Adherence level of antihypertensive agents in coronary artery disease. Brit J Clin Pharmacol 2010; 69(1): 74-84.

Prescriptions filled during pregnancy for drugs with the potential of fetal harm - Kulaga S, Zargarzadeh A, Bérard A. Prescriptions filled during pregnancy for drugs with the potential of fetal harm. BJOG 2009; 116(13): 1788-95; Erratum in: BJOG. 2010;117(3):373.

Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia among women with chronic hypertension - Nakhai-Pour HR, Rey E, Bérard A. Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia among women with chronic hypertension. Am J Obstet Gynecol 2009; 201(2): 180.e1-8.

Validity of perinatal pharmacoepidemiologic studies using data from the RAMQ administrative database - Bérard A, Lacasse A. Validity of perinatal pharmacoepidemiologic studies using data from the RAMQ administrative database. Can J Clin Pharmacol 2009; 16(2): e360-369.

Better data needed from pregnancy registries - Balken E, Bérard A, Braddock S, Briggs G, Chambers C, Einarson A, Gaffaney CL, Gaudette M, Koren G, Jones K, Lamm S, Miller R, Polifka J, Riordan S, Robinson L, Soldin O, Wisner K, Wolfe L. Better data needed from pregnancy registries. Birth Defects Res Part A Clin Mol Teratol 2009; 85(2): 109-111.

Metoclopramide and diphenhydramine in the treatment of hyperemesis gravidarum: effectiveness and predictors of rehospitalisation - Lacasse A, Lagoutte A, Ferreira E, Bérard A. Metoclopramide and diphenhydramine in the treatment of hyperemesis gravidarum: effectiveness and predictors of rehospitalisation. Eur J Obstet Gynecol Reprod Biol 2009; 143(1): 43-49.

Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention - Kettani FZ, Dragomir A, Côté R, Roy L, Bérard A, Blais L, Lalonde L, Moreau P, Perreault S. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009; 40(1): 213-220.

Epidemiology of nausea and vomiting of pregnancy: prevalence, severity, determinants, and the importance of race/ethnicity - Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Epidemiology of nausea and vomiting of pregnancy: prevalence, severity, determinants, and the importance of race/ethnicity. BMC Pregnancy and Childbirth 2009; 9: 26 (on line).

Better adherence to antihypertensive agents and risk reduction of chronic heart failure - Perreault S, Dragomir A, White M, Lalonde L, Blais L, Bérard A. Better adherence to antihypertensive agents and risk reduction of chronic heart failure. J Iinter Med 2009; 266(2): 207-218.

Effect of statin adherence on cerebrovascular disease in primary prevention - Perreault S, Elia L, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L. Effect of statin adherence on cerebrovascular disease in primary prevention. Am J Med 2009; 122(7): 647-655.

Herbal products use during pregnancy: prevalence and predictors - Moussally K, Oraichi D, Bérard A. Herbal products use during pregnancy: prevalence and predictors. Pharmacoepidemiol Drug Safety 2009; 18(6): 454-461.

Determinants of early medical management of nausea and vomiting of pregnancy - Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Determinants of early medical management of nausea and vomiting of pregnancy. Birth 2009; 36(1): 70-77.

Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation - Gendron M-P, Martin B, Oraichi D, Bérard A. Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation. Eur J Clin Pharmacol 2009; 65(5): 523-531.

Impact of better adherence to statin agents in the primary prevention of coronary artery disease - Perreault S, Dragomir A, Blais L, Bérard A, Lalonde L, White M, Pilon D. Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol 2009; 65(10): 1013-1024.

Duration of antidepressant use during pregnancy and risk of major congenital malformations - Ramos É, St-André M, Rey E, Oraichi D, Bérard A. Duration of antidepressant use during pregnancy and risk of major congenital malformations. Brit J Psychiat 2008; 192(5): 344-350.

The priorities of public health must participate in the regulation of health networks - Bérard A, Bréchat PH, Scapin MH. The priorities of public health must participate in the regulation of health networks. Presse Med 2008; 37(5 Pt 1): 739-741.

[Organisation of systems of care. Channels and networks of care] - Bérard A. [Organisation of systems of care. Channels and networks of care]. Rev Prat 2008; 58(3): 327-331.

????The modified-PUQE : A global index for assessment of nausea and vomiting of pregnancy severity in the first trimester of gestation - Bérard A, Lacasse A. The modified-PUQE : A global index for assessment of nausea and vomiting of pregnancy severity in the first trimester of gestation. Am J Obstet Gynecol 2008; (sous presse).

No racial or ethnic disparity in treatment of long-bone fractures - Bijur PE, Bérard A, Nestor J, Calderon Y, Davitt M, Gallagher EJ. No racial or ethnic disparity in treatment of long-bone fractures. Am J Emerg Med 2008; 26(3): 270-274.

Validation of the nausea and vomiting of pregnancy specific health related quality of life questionnaire - Lacasse A, Bérard A. Validation of the nausea and vomiting of pregnancy specific health related quality of life questionnaire. Health Qual Life Outcomes 2008; 6: 32 (on line).

Race, ethnicity, and management of pain from long-bone fractures: a prospective study of two academic urban emergency departments - Bijur PE, Bérard A, Esses D, Calderon Y, John Gallagher E. Race, ethnicity, and management of pain from long-bone fractures: a prospective study of two academic urban emergency departments. Acad Emerg Med 2008; 15(7): 589-597.

Impact of adherence to statins on chronic heart failure in primary prevention - Perreault S, Dragomir A, Blais L, Bérard A, Lalonde L, White M. Impact of adherence to statins on chronic heart failure in primary prevention. Brit J Clin Pharmacol 2008; 66(5): 706-716.

Nausea and vomiting of pregnancy: what about quality of life? - Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Nausea and vomiting of pregnancy: what about quality of life?. BJOG 2008; 115(12): 1484-1493.

MotherNature: establishing a Canadian research network for natural health products (NHPs) during pregnancy and lactation - Koren G, Dugoua JJ, Magee LA, Vohra S, Matsui D, Bérard A, Johnson B, Moretti M, Einarson A. MotherNature: establishing a Canadian research network for natural health products (NHPs) during pregnancy and lactation. J Altern Complement Med 2008; 14(4): 369-372.

Risk factors associated with preterm birth according to gestational age at birth - Ofori B, Le Tiec M, Bérard A. Risk factors associated with preterm birth according to gestational age at birth. Pharmacoepidemiol Drug Safety 2008; 17(6): 556-564.

Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy - Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am J Obstet Gynecol 2008; 198(1): 71.e1-7.

Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study - Azoulay L, Blais L, Koren G, LeLorier J, Bérard A. Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry 2008; 69(4): 526-532.

Antidepressant therapy during pregnancy: an insight on its potential healthcare costs - Ramos É, Ofori B, Oraichi D, Bérard A. Antidepressant therapy during pregnancy: an insight on its potential healthcare costs. Can J Clin Pharmacol 2008; 15(3): e398-410.

[Antidepressants and pregnancy: risks and benefits for the mother and child] - Bérard A, Ramos A. [Antidepressants and pregnancy: risks and benefits for the mother and child]. Méd Sci (Paris) 2007; 23(11): 957-960.

Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective - Bérard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Brit J Clin Pharmacol 2007; 63(2): 196-205.

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage - Bérard A, Ramos É, Rey E, Blais L, St-André M, Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res Part B Dev Reprod Toxicol 2007; 80(1): 18-27.

Risk of congenital anomalies in pregnant users of statin drugs - Ofori B, Rey E, Bérard A. Risk of congenital anomalies in pregnant users of statin drugs. Brit J Clin Pharmacol 2007; 64(4): 496-509.

Prevalence and predictors of antidepressant use in a cohort of pregnant women - Ramos É, Oraichi D, Rey E, Blais L, Bérard A. Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG 2007; 114(9): 1055-1064.

Risk of drug interactions among children accessing drugs through Health Canada’s special access programme - Atkinson S, Blanc A, Lebel D, Bussières J-F, Bailey B, Bérard A. Risk of drug interactions among children accessing drugs through Health Canada’s special access programme. Can J Hospital Pharmacy 2007; 60: 114-120.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors - Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther 2007; 29(5): 918-926.

Observance au traitement antirétroviral chez les femmes enceintes atteintes du VIH avant et après un conseil pharmaceutique - Aubin PH, Cloutier K, Dubé F, Ferreira E, Bussières J-F, Lebel D, Bérard A. Observance au traitement antirétroviral chez les femmes enceintes atteintes du VIH avant et après un conseil pharmaceutique. Pharmactuel 2007; 40(1): 15-24.

Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates - Ferreira E, Carceller A, Agogué C, Martin B, St-André M, Francoeur D, Bérard A. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics 2007; 119(1): 52-59.

Impact of adherence to statins on coronary artery disease in primary prevention - Bouchard M, Dragomir A, Blais L, Bérard A, Pilon D, Perreault S. Impact of adherence to statins on coronary artery disease in primary prevention. Brit J Clin Pharmacol 2007; 63(6): 698-708.

Isotretinoin therapy and the incidence of acne relapse: a nested case-control stdy - Azoulay L, Oraichi D, Bérard A. Isotretinoin therapy and the incidence of acne relapse: a nested case-control stdy. Brit J Dermatol 2007; 157(6): 1240-1248.

Factors associated with long-term benzodiazepine use among elderly women and men in Québec - Fortin D, Préville M, Ducharme C, Hébert R, Trottier L, Grégoire JP, Allard J, Bérard A. Factors associated with long-term benzodiazepine use among elderly women and men in Québec . J Women Aging 2007; 19(3-4): 37-52.

Lack of influence of patient self-report of pain intensity on administration of opioids for suspected long-bone fractures - Bijur PE, Bérard A, Esses D, Nestor J, Schechter C, Gallagher J. Lack of influence of patient self-report of pain intensity on administration of opioids for suspected long-bone fractures. J Pain 2006; 7(6): 438-444.

Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study - Ofori B, Oraichi D, Blais L, Rey E, Bérard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study. Birth Defects Res Part B Dev Reprod Toxicol 2006; 77(4): 268-279.

Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern? - Azoulay L, Oraichi D, Bérard A. Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?. Eur J Clin Pharmacol 2006; 62(8): 667-674.

Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department - Hohl CM, Robitaille C, Lord V, Dankoff J, Colacone A, Pham B, Bérard A, Pepin J, Afilalo M. Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department. Acad Emerg Med 2005; 12(3): 197-205.

Correlates of quality of life in patients with asthma - Laforest L, Pacheco Y, Bartsch P, Vincken W, Pietri G, Ernst P, Bérard A, Van Ganse E. Correlates of quality of life in patients with asthma. Ann Allergy Asthma Immunol 2005; 94(4): 473-479.

Utilisation du programme d'accès spécial pour les pharmaciens du Québec et comparaison avec d'autres pays - Bussières J-F, Atkinson S, Blanc A, Lebel D, Bailey B, Bérard A. Utilisation du programme d'accès spécial pour les pharmaciens du Québec et comparaison avec d'autres pays. Can J Hospital Pharmacy 2005; 58(2): 79-89.

Facteurs associés a la consommation de courte et de longue durée des benzodiazepines chez les personnes agées du Quebec - Fortin D, Préville M, Ducharme C, Hébert R, Allard J, Grégoire JP, Trottier L, Bérard A. Facteurs associés a la consommation de courte et de longue durée des benzodiazepines chez les personnes agées du Quebec. Can J Aging 2005; 24(2): 103-114.

Inappropriate medication prescribing in community-dwelling elderly people living in Isfahan - Azoulay L, Zargarzadeh A, Oraichi D, Bérard A. Inappropriate medication prescribing in community-dwelling elderly people living in Isfahan. Eur J Clin Pharmacol 2005; 61(12): 913-919.

Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study - Souverein PC, Bérard A, van Staa TP, Cooper C, Leufkens HGM, Walker BR. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 2004; 90(8): 859-865.

The influence of venous thromboembolism on quality of life and severity of chronic venous diseases - Kahn SR, M'Ian CE, Lamping D, Kurz X, Bérard A, Abenhaim L, and the VEINES group. The influence of venous thromboembolism on quality of life and severity of chronic venous diseases. Thromb Haemost 2004; 2(21): 2146-2151.

Relationship between clinical severity of chronic venous disease and patient-reported quality of life: results from an international cohort study - Kahn A, M'Ian CE, Lamping D, Kurz X, Bérard A, Abenhaim L, and the VEINES group. Relationship between clinical severity of chronic venous disease and patient-reported quality of life: results from an international cohort study. J Vasc Surg 2004; 39(4): 823-828.

Utilisation des anxiolytiques, sédatifs et hypnotiques chez les personnes âgées vivant dans la communauté: construction d'un cadre conceptuel - Préville M, Ducharme C, Fortin D, Hébert R, Allard J, Grégoire JP, Bérard A, Trottier L. Utilisation des anxiolytiques, sédatifs et hypnotiques chez les personnes âgées vivant dans la communauté: construction d'un cadre conceptuel. Santé mentale au Québec 2003; 28(2): 165-182.

Validity of the Leg-O-Meter, an instrument to measure leg circumference - Bérard A, Kurz X, Zuccarelli F, Abenhaim L, and the VEINES group. Validity of the Leg-O-Meter, an instrument to measure leg circumference. Angiology 2002; 53: 21-28.

Risk factors for the first-time development of venous ulcers of the lower limbs: the influence of heredity and physical activity - Bérard A, Abenhaim L, Platt RW, Kahn SR, Steinmetz O. Risk factors for the first-time development of venous ulcers of the lower limbs: the influence of heredity and physical activity. Angiology 2002; 53(6): 647-657.

À propos de cette page

Créée le 22 juillet 2014
Signaler ou faire une remarque

Chaque dollar compte !

Merci de votre générosité.

Ce sont les donateurs comme vous qui nous permettent d’accélérer la recherche, de guérir, à chaque année, plus d’enfants et continuer d’offrir un des meilleurs niveaux de santé au monde.

Il est également possible de donner par la poste ou de donner par téléphone au numéro sans frais

1-888-235-DONS (3667)

Nous contacter

514 345-4931

Légal

© 2006-2014 Centre de recherche du CHU Sainte-Justine.
Tous droits réservés.
Avis légaux  Confidentialité  Sécurité

Avertissement

Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine